miR-107 Cancer Research Results

miR-107, MicroRNA-107: Click to Expand ⟱
Source:
Type:

miR-107 - MicroRNA-107

Abbreviation: miR-107

Type: MicroRNA / post-transcriptional gene-expression regulator

Function: miR-107 is a regulatory microRNA that suppresses target mRNAs through sequence-specific post-transcriptional repression. It influences cell-cycle control, metabolism, angiogenesis, migration, epithelial-mesenchymal transition, neuronal function, and amyloid precursor protein processing. One important neurological target is BACE1, the major β-secretase involved in amyloid-β production.

Cancer: ↕ Context-dependent. miR-107 functions as a tumor-suppressive microRNA in many experimental cancers, where increased miR-107 can inhibit proliferation, migration, invasion, angiogenesis, and epithelial-mesenchymal transition. However, oncogenic activity has also been reported in selected tumor types, so its effect depends on the dominant downstream targets and cellular context.

Alzheimer's Disease: ↓ Reduced miR-107 has been reported in Alzheimer's disease and may contribute to increased BACE1 expression and amyloidogenic APP processing. Increased miR-107 can suppress BACE1 and is therefore generally considered favorable for reducing amyloid-β production, although miR-107 also regulates additional neuronal and metabolic targets.
Scientific Papers found: Click to Expand⟱
7912- IVT,    Isovitexin modulates autophagy in Alzheimer’s disease via miR-107 signalling
- in-vivo, AD, NA
*memory↑, *Aβ↓, *NeuroI↓, *PI3K↓, *Akt↓, *mTOR↓, *miR-107↑,
8384- LT,    Current situation and research progress of luteolin in the treatment of gastrointestinal malignant tumors
- Review, GC, NA
Apoptosis↑, TumAuto↑, TumCCA↑, EMT↓, *ROS↓, *antiOx↑, ROS↑, P53↑, LC3II↑, Beclin-1/ATG6↑, p‑MAP2K1/MEK1↓, p‑ERK↓, BAX↑, cl‑Casp3↑, Bcl-2↓, p‑MAPK↓, DNArepair↓, HMGB1↓, XRCC1↓, ERCC3↑, CycB/CCNB1↓, CDC2↓, p‑CHK1↑, TumCCA↑, TumCP?, Wnt↓, β-catenin/ZEB1↓, miR-384↑, PTN↓, MMP2↓, MMP3↓, MMP9↓, MMP16↓, Ferroptosis↑, GPx4↓, Synergy↑, Ki-67↓, GSH↓, ChemoSen↑, TumCP↓, TumCMig↓, TumCI↓, PI3K↓, Akt↓, mTOR↓, NF-kB↓, NOTCH↓, miR-139-5p↑, miR-34a↑, miR-422a↑, miR-107↑, miR-21↓, miR-155↓, miR-224↓, miR-340↓, E-cadherin↑, N-cadherin↓, Vim↓, HK1↓, FOXO1↓, compI↓, compIII↓, compV↓, ETC↓, BioAv↝,
8397- LT,    Effects and Mechanisms of Luteolin, a Plant-Based Flavonoid, in the Prevention of Cancers via Modulation of Inflammation and Cell Signaling Molecules
- Review, Var, NA
tumCV↓, TumCP↓, angioG↓, TumCI↓, TumMeta↓, mTOR↓, PI3K↓, Akt↓, STAT3↓, Wnt↓, β-catenin/ZEB1↓, TumCCA↑, Apoptosis↑, hTERT/TERT↓, AP-1↓, NF-kB↓, MAPK↓, HSP90↓, AR↓, IGF-1R↓, Akt↓, NOTCH↓, IL6↓, MMP2↓, MMP3↓, MMP9↓, MMP16↓, TumVol∅, TumW∅, miR-34a↑, miR-107↑, miR-139-5p↑, miR-422a↑, miR-21↓, miR-155↓, miR-224↓, miR-340↓, *toxicity↓,

Showing Research Papers: 1 to 3 of 3

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

GPx4↓, 1,   GSH↓, 1,   ROS↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

CDC2↓, 1,   compI↓, 1,   compIII↓, 1,   compV↓, 1,   ETC↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

HK1↓, 1,  

Cell Death(tgid=5) ⓘ

Apoptosis↑, 2,   BAX↑, 1,   Bcl-2↓, 1,   cl‑Casp3↑, 1,   Ferroptosis↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 3,   p‑ERK↓, 1,   IGF-1R↓, 1,   p‑MAP2K1/MEK1↓, 1,   MAPK↓, 1,   p‑MAPK↓, 1,   mTOR↓, 2,   PI3K↓, 2,   STAT3↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

FOXO1↓, 1,   miR-107↑, 2,   miR-139-5p↑, 2,   miR-155↓, 2,   miR-21↓, 2,   miR-224↓, 2,   miR-340↓, 2,   miR-34a↑, 2,   miR-384↑, 1,   miR-422a↑, 2,   tumCV↓, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

HSP90↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↑, 1,   LC3II↑, 1,   TumAuto↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNArepair↓, 1,   ERCC3↑, 1,   hTERT/TERT↓, 1,   P53↑, 1,   XRCC1↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

p‑CHK1↑, 1,   CycB/CCNB1↓, 1,   Ki-67↓, 1,   TumCCA↑, 3,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Ki-67↓, 1,   NOTCH↓, 2,   TumCP?, 1,   TumCP↓, 2,   Wnt↓, 2,  

Migration(tgid=13) ⓘ

AP-1↓, 1,   E-cadherin↑, 1,   EMT↓, 1,   MMP16↓, 2,   MMP2↓, 2,   MMP3↓, 2,   MMP9↓, 2,   N-cadherin↓, 1,   TumCI↓, 2,   TumCMig↓, 1,   TumMeta↓, 1,   Vim↓, 1,   β-catenin/ZEB1↓, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

HMGB1↓, 1,   IL6↓, 1,   NF-kB↓, 2,  

Synaptic & Neurotransmission(tgid=18) ⓘ

PTN↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↝, 1,   ChemoSen↑, 1,   Synergy↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AR↓, 1,   hTERT/TERT↓, 1,   IL6↓, 1,  

Functional Outcomes(tgid=23) ⓘ

TumVol∅, 1,   TumW∅, 1,  
Total Targets: 79

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 1,   ROS↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 1,   mTOR↓, 1,   PI3K↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

miR-107↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

NeuroI↓, 1,  

Protein Aggregation(tgid=19) ⓘ

Aβ↓, 1,  

Functional Outcomes(tgid=23) ⓘ

memory↑, 1,   toxicity↓, 1,  
Total Targets: 10

Scientific Paper Hit Count for: miR-107, MicroRNA-107
2 Luteolin
1 Isovitexin
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:1720  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page